An article in the UK’s Times Online looks into the personal genetic testing business, saying that a lot of the promise it held a year and a half ago has been “postponed.” “The fledgeling industry’s struggles to take wing have brought comparisons with the dot-com bubble of a decade ago,” the article begins and then delves into the various approaches the different companies are taking.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.